Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice

Researchers gave aging mice dasatinib and quercetin, drugs intended to remove worn-out cells. They compared them with aging mice that did not receive the treatment. The treated mice had healthier-looking intervertebral discs, the soft cushions between the bones of the spine. They also showed fewer signs of cell aging and inflammation.

What this means for you: This is an encouraging result in mice, but it does not show that the treatment works or is safe in humans. You can ignore this as a reason to buy quercetin or seek dasatinib for back problems.